Inhibitors of prolyl endopeptidase
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 22, 2009
Grant Date -
Oct 12, 2006
app pub date -
Apr 7, 2006
filing date -
Apr 11, 2005
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to novel inhibitors of prolyl endopeptidase of formula (1)wherein I, A, X, Y and Z are specified in the description. The compounds are useful for the treatment of diseases such as mild cognitive impairment (MCI), Alzheimer's disease, Down Syndrome, Parkinson disease and Chorea Huntington.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully